Genoplan Asia Pacific

Genoplan, is a series B startup based in Korea, Japan and Singapore with accumulated funding of US18 million. It provides a B2B2C genetic & health analytics platform for Insurers in Asia. Through our technology in genetic analysis, we analyzes user’s saliva to provide individuals with their genetic profile and personalized recommendation to lifestyle change, including diet, health food, work-out, and cosmetics. The company was incorporated in 2014, and has operations at Seoul, Korea and Fukuoka & Tokyo, Japan, and Singapore.